Kezar Life Sciences, Inc. Common Stock

KZRNASDAQUSD
7.40 USD
0.00 (0.00%)AT CLOSE (11:59 AM EDT)
7.51
0.11 (1.43%)
POST MARKET (AS OF 06:10 PM EDT)
Post Market
AS OF 06:10 PM EDT
7.51
0.11 (1.43%)
🔴Market: CLOSED
Open?$7.36
High?$7.55
Low?$7.35
Prev. Close?$7.40
Volume?53.4K
Avg. Volume?69.4K
VWAP?$7.41
Rel. Volume?0.77x
Bid / Ask
Bid?$7.31 × 1.0K
Ask?$7.70 × 100
Spread?$0.39
Midpoint?$7.51
Valuation & Ratios
Market Cap?54.5M
Shares Out?N/A
Float?4.8M
Float %?65.8%
P/E Ratio?N/A
P/B Ratio?0.78
EPS?-$7.60
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?11.52Strong
Quick Ratio?11.52Strong
Cash Ratio?10.93Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A
P/B?
0.78CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
0.3CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
-80.0%WEAK
ROA?
-73.1%WEAK
Cash Flow & Enterprise
FCF?$-51785000
Enterprise Value?$-17328700
Related Companies
Loading...
News
Profile
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
Employees
9
Market Cap
54.5M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2018-06-21
Address
4000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-822-5600